DASANIX (DASATINIB) 50MG TABLETS 60`S

Description

Effective Oral Therapy for Blood Cancer

DASANIX (Dasatinib) 50mg Tablets 60’s provide a targeted treatment for patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). As a second-generation tyrosine kinase inhibitor (TKI), dasatinib helps to block abnormal signals that allow leukemia cells to grow uncontrollably.

How DASANIX Works

Dasatinib works by inhibiting BCR-ABL and other kinases involved in cancer cell signalling pathways. As a result, DASANIX (Dasatinib) 50mg Tablets 60’s slow down cancer cell growth and promote remission. Additionally, this oral treatment option supports better long-term outcomes in patients who are newly diagnosed or resistant to prior therapies.

Dosage and Administration

Your healthcare provider will determine the appropriate dose based on your condition, treatment stage, and tolerance. For many patients, 50mg tablets allow flexible dosing adjustments, especially during early or maintenance phases. Take DASANIX with or without food, at the same time each day. Swallow the tablet whole, and avoid using antacids within two hours of dosing.

Monitoring and Side Effects

Regular monitoring of blood counts, liver function, and heart health is essential during treatment. Common side effects include fluid retention, diarrhoea, fatigue, headache, and skin rashes. Although rare, serious effects like low platelet counts or pleural effusion may occur. Therefore, it’s vital to report any unusual symptoms promptly.

Reliable Quality and Support

Manufactured under strict pharmaceutical standards, DASANIX ensures consistent potency and quality. It is a prescription-only medication and should always be taken under the guidance of an oncologist or hematologist.

Supporting Your Cancer Journey

With strong clinical backing and a proven mechanism of action, DASANIX offers a reliable path toward better control of leukemia—empowering patients every step of the way.